These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3342366)

  • 21. Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma.
    Tanaka M; Kaneda Y; Fujii S; Yamano T; Hashimoto K; Huang SK; Hoon DS
    Mol Ther; 2002 Mar; 5(3):291-9. PubMed ID: 11863419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
    Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H
    BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alum with interleukin-12 augments immunity to a melanoma peptide vaccine: correlation with time to relapse in patients with resected high-risk disease.
    Hamid O; Solomon JC; Scotland R; Garcia M; Sian S; Ye W; Groshen SL; Weber JS
    Clin Cancer Res; 2007 Jan; 13(1):215-22. PubMed ID: 17200357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cells.
    Lotem M; Machlenkin A; Hamburger T; Nissan A; Kadouri L; Frankenburg S; Gimmon Z; Elias O; David IB; Kuznetz A; Shiloni E; Peretz T
    Clin Cancer Res; 2009 Aug; 15(15):4968-77. PubMed ID: 19602547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and clinical activity of a polyvalent melanoma antigen vaccine prepared from shed antigens.
    Bystryn JC
    Ann N Y Acad Sci; 1993 Aug; 690():190-203. PubMed ID: 8368738
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterization of polyvalent allogeneic vaccines.
    Van Epps D
    Dev Biol (Basel); 2004; 116():79-90; discussion 133-43. PubMed ID: 15603185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.
    Barth A; Hoon DS; Foshag LJ; Nizze JA; Famatiga E; Okun E; Morton DL
    Cancer Res; 1994 Jul; 54(13):3342-5. PubMed ID: 8012946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
    Chapman PB; Wu D; Ragupathi G; Lu S; Williams L; Hwu WJ; Johnson D; Livingston PO
    Clin Cancer Res; 2004 Jul; 10(14):4717-23. PubMed ID: 15269144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide.
    Berd D; Maguire HC; Mastrangelo MJ
    Cancer Res; 1984 Nov; 44(11):5439-43. PubMed ID: 6488195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the techniques used for monitoring humoral immunity in cancer patients.
    Renk CM; Gupta RK; Irie RF; Morton DL
    J Surg Oncol; 1982 Mar; 19(3):155-61. PubMed ID: 7040819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative study of cyclophosphamide, 6-mercaptopurine, azathiopurine and methotrexate. Relative effects on the humoral and the cellular immune response in the mouse.
    Otterness IG; Chang YH
    Clin Exp Immunol; 1976 Nov; 26(2):346-54. PubMed ID: 991462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between immune response to melanoma vaccine immunization and clinical outcome in stage II malignant melanoma.
    Bystryn JC; Oratz R; Roses D; Harris M; Henn M; Lew R
    Cancer; 1992 Mar; 69(5):1157-64. PubMed ID: 1739915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of adjuvant on induction of protective immunity by a non-living vaccine against schistosomiasis.
    James SL; Pearce EJ
    J Immunol; 1988 Apr; 140(8):2753-9. PubMed ID: 3128608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy.
    Okamoto T; Irie RF; Fujii S; Huang SK; Nizze AJ; Morton DL; Hoon DS
    J Invest Dermatol; 1998 Dec; 111(6):1034-9. PubMed ID: 9856813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of melanoma antigens that are immunogenic in humans and expressed in vivo.
    Applebaum J; Reynolds S; Knispel J; Oratz R; Shapiro R; Bystryn JC
    J Natl Cancer Inst; 1998 Jan; 90(2):146-9. PubMed ID: 9450575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccine-induced CD8+ T-cell responses to MAGE-3 correlate with clinical outcome in patients with melanoma.
    Reynolds SR; Zeleniuch-Jacquotte A; Shapiro RL; Roses DF; Harris MN; Johnston D; Bystryn JC
    Clin Cancer Res; 2003 Feb; 9(2):657-62. PubMed ID: 12576432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental and clinical studies with active specific immunotherapy.
    Livingston PO
    Prog Clin Biol Res; 1989; 288():309-21. PubMed ID: 2654953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel adjuvant, a mixture of alum and the general opioid antagonist naloxone, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.
    Jazani NH; Sohrabpour M; Mazloomi E; Shahabi S
    FEMS Immunol Med Microbiol; 2011 Feb; 61(1):54-62. PubMed ID: 21054579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.